Actively Recruiting
A Real World Study of Sacituzumab Govitecan
Led by Fudan University · Updated on 2025-05-11
100
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical Outcomes and Safety of Sacituzumab Govitecan in Metastatic HER-2 negative Breast Cancer Patients
CONDITIONS
Official Title
A Real World Study of Sacituzumab Govitecan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 or above
- Eastern Cooperative Oncology Group (ECOG) physical condition score 62
- Unresectable or metastatic triple-negative breast cancer confirmed by tumor histology or cytology, with at least two prior systemic treatments (one for metastatic disease); or HR+/HER2- unresectable or metastatic breast cancer with prior endocrine therapy and at least two lines of systemic therapy for metastatic disease
- Currently receiving Sacituzumab Govitecan treatment in advanced stage
- Willing to follow the trial protocol and attend regular follow-ups during the study
- Women of childbearing age, fertile men, or their partners agree to use effective contraception or have no plans for fertility or sperm donation during the study and for six months after the last dose
You will not qualify if you...
- Pregnant or lactating women
- Having acute or chronic infections or other serious diseases deemed unsuitable by researchers
- History of other malignant tumors within 5 years, except for certain cured cancers or fully cured second primary cancers without recurrence
- Mental illness, poor compliance, or inability to cooperate or report treatment responses
- Severe organic diseases or major organ failure (heart, lung, liver, or kidney) preventing treatment tolerance
- Allergy to Sacituzumab Govitecan
- Changed treatment regimens after Sacituzumab Govitecan for reasons other than disease progression
- Any other conditions judged by researchers as unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
J
Jian Zhang, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here